Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication

NCT00152581 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C, HCV Genotype 1

Interventions

DRUG: Pegylated interferon-alfa2a (Pegasys); ribavirin

Sponsor

University College London Hospitals